BALA CYNWYD, Pa., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Karuna Therapeutics, Inc. (Nasdaq – KRTX)

Under the terms of the Merger Agreement, Karuna Therapeutics will be acquired by Bristol Myers Squibb (NYSE: BMY) in an all-cash transaction valued at approximately $14 billion. Karuna Therapeutics stockholders will receive $330.00 per share in cash upon completion of the proposed transaction. The investigation concerns whether the Karuna Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Bristol Myers Squibb is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/karuna-therapeutics-inc-nasdaq-krtx/.

Carrols Restaurant Group, Inc. (Nasdaq - TAST)

Under the terms of the agreement, Carrols will be acquired by Restaurant Brands International Inc. (“RBI”) (NYSE: QSR). Carrols shareholders will receive $9.55 per share in an all cash transaction, or an aggregate total enterprise value of approximately $1.0 billion. The investigation concerns whether the Carrols Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether RBI is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/carrols-restaurant-group-inc-nasdaq-tast/.

Ansys, Inc. (Nasdaq - ANSS)

Under the terms of the agreement, Ansys will be acquired by Synopsys (Nasdaq - SNPS). Ansys shareholders will receive $197.00 in cash and 0.3450 shares of Synopsys common stock for each Ansys share, representing an enterprise value of approximately $35 billion based on the closing price of Synopsys common stock on December 21, 2023. Ansys shareholders are expected to own approximately 16.5% of the combined company on a pro forma basis. The investigation concerns whether the Ansys Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Synopsys is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/ansys-inc-nasdaq-anss/.

HomeStreet, Inc. (Nasdaq - HMST)

Under the terms of the agreement, HomeStreet will be acquired by FirstSun Capital Bancorp (“FirstSun” (OTCQX - FSUN). The companies will combine in an all-stock transaction in which HomeStreet shareholders will receive 0.4345 of a share of FirstSun common stock for each share of HomeStreet common stock which represents a value of $14.75 per share. The investigation concerns whether the HomeStreet Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether FirstSun is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/homestreet-inc-nasdaq-hmst/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.